At-home testing company Reperio partners with Amazon
Amazon also recently announced an agentic AI tool last month.
• less than 3 min read
Cassie McGrath is a reporter at Healthcare Brew, where she focuses on the inner-workings and business of hospitals, unions, policy, and how AI is impacting the industry.
Tech giant Amazon delved deeper into the healthcare industry on Jan. 28, announcing a new partnership with at-home testing company Reperio Health.
Now, Reperio’s users have access to Amazon’s primary care arm One Medical and can use Reperio’s screening kits, which include blood pressure, heart rate, BMI, relative fat mass, blood glucose, and complete lipid panel testing. The entire testing process takes 30 minutes to one hour, according to a release, and results are delivered “immediately” through the company’s app.
Reperio contracts with employers and health plans, then connects patients to virtual appointments on its platform, where clinicians go over results and other medical history.
With this partnership, patients can also continue their care on One Medical for treatment.
“Preventive care is having its Amazon moment,” Travis Rush, CEO and co-founder of Reperio Health, said in the release. “We are ensuring that preventive care and a long-term primary care relationship can get to the communities and patients who have all too often been left behind.”
This news comes soon after Amazon announced a new agentic AI tool for One Medical members. In November, Amazon also announced a direct-to-consumer medication service.
Navigate the healthcare industry
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
Navigate the healthcare industry
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.